Walgreens Boots Alliance Financial Statements (WBA)
|
|
|
|
Report date
|
|
|
13.10.2022 |
23.11.2022 |
12.10.2023 |
22.11.2023 |
15.10.2024 |
|
15.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
132 703 |
132 703 |
139 081 |
139 081 |
147 658 |
|
147 657 |
|
Operating Income, bln rub |
|
|
1 387 |
4 385 |
-6 882 |
-6 882 |
-14 076 |
|
-14 076 |
|
EBITDA, bln rub |
? |
|
4 955 |
6 375 |
-2 582 |
3 479 |
-11 278 |
|
-11 534 |
|
Net profit, bln rub |
? |
|
4 337 |
4 337 |
-3 080 |
-3 080 |
-8 636 |
|
-8 636 |
|
|
OCF, bln rub |
? |
|
3 899 |
3 899 |
2 258 |
2 258 |
1 018 |
|
1 018 |
|
CAPEX, bln rub |
? |
|
1 734 |
1 734 |
2 117 |
2 117 |
1 381 |
|
1 381 |
|
FCF, bln rub |
? |
|
2 165 |
2 165 |
141.0 |
141.0 |
-363.0 |
|
-363.0 |
|
Dividend payout, bln rub
|
|
|
1 659 |
1 659 |
1 659 |
1 659 |
1 260 |
|
1 260 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
38.3% |
38.3% |
0.00% |
0.00% |
0.00% |
|
-14.6% |
|
|
OPEX, bln rub |
|
|
26 879 |
27 295 |
34 205 |
33 954 |
40 600 |
|
40 598 |
|
Cost of production, bln rub |
|
|
104 437 |
104 437 |
112 009 |
112 009 |
121 134 |
|
121 135 |
|
R&D, bln rub |
|
|
307.0 |
307.0 |
371.0 |
371.0 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
396.0 |
400.0 |
580.0 |
580.0 |
482.0 |
|
482.0 |
|
|
Assets, bln rub |
|
|
90 124 |
90 124 |
96 628 |
96 628 |
81 037 |
|
81 037 |
|
Net Assets, bln rub |
? |
|
29 366 |
29 366 |
20 021 |
20 021 |
10 445 |
|
10 445 |
|
Debt, bln rub |
|
|
35 477 |
35 477 |
33 534 |
33 534 |
32 852 |
|
32 852 |
|
Cash, bln rub |
|
|
2 472 |
2 472 |
739.0 |
739.0 |
3 110 |
|
3 109 |
|
Net debt, bln rub |
|
|
33 005 |
33 005 |
32 795 |
32 795 |
29 742 |
|
29 743 |
|
|
Ordinary share price, rub |
|
|
35.1 |
35.1 |
25.3 |
25.3 |
9.25 |
|
21.5 |
|
Number of ordinary shares, mln |
|
|
864.4 |
864.4 |
863.2 |
863.2 |
863.1 |
|
863.7 |
|
|
Market cap, bln rub |
|
|
30 306 |
30 306 |
21 848 |
21 848 |
7 984 |
|
18 595 |
|
EV, bln rub |
? |
|
63 311 |
63 311 |
54 643 |
54 643 |
37 726 |
|
48 338 |
|
Book value, bln rub |
|
|
-3 644 |
-3 644 |
-21 801 |
-21 801 |
-18 034 |
|
-18 034 |
|
|
EPS, rub |
? |
|
5.02 |
5.02 |
-3.57 |
-3.57 |
-10.0 |
|
-10.00 |
|
FCF/share, rub |
|
|
2.50 |
2.50 |
0.16 |
0.16 |
-0.42 |
|
-0.42 |
|
BV/share, rub |
|
|
-4.22 |
-4.22 |
-25.3 |
-25.3 |
-20.9 |
|
-20.9 |
|
|
EBITDA margin, % |
? |
|
3.73% |
4.80% |
-1.86% |
2.50% |
-7.64% |
|
-7.81% |
|
Net margin, % |
? |
|
3.27% |
3.27% |
-2.21% |
-2.21% |
-5.85% |
|
-5.85% |
|
FCF yield, % |
? |
|
7.14% |
7.14% |
0.65% |
0.65% |
-4.55% |
|
-1.95% |
|
ROE, % |
? |
|
14.8% |
14.8% |
-15.4% |
-15.4% |
-82.7% |
|
-82.7% |
|
ROA, % |
? |
|
4.81% |
4.81% |
-3.19% |
-3.19% |
-10.7% |
|
-10.7% |
|
|
P/E |
? |
|
6.99 |
6.99 |
-7.09 |
-7.09 |
-0.92 |
|
-2.15 |
|
P/FCF |
|
|
14.0 |
14.0 |
154.9 |
154.9 |
-22.0 |
|
-51.2 |
|
P/S |
? |
|
0.23 |
0.23 |
0.16 |
0.16 |
0.05 |
|
0.13 |
|
P/BV |
? |
|
-8.32 |
-8.32 |
-1.00 |
-1.00 |
-0.44 |
|
-1.03 |
|
EV/EBITDA |
? |
|
12.8 |
9.93 |
-21.2 |
15.7 |
-3.35 |
|
-4.19 |
|
Debt/EBITDA |
|
|
6.66 |
5.18 |
-12.7 |
9.43 |
-2.64 |
|
-2.58 |
|
|
R&D/CAPEX, % |
|
|
17.7% |
17.7% |
17.5% |
17.5% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
1.31% |
1.31% |
1.52% |
1.52% |
0.94% |
|
0.94% |
|
| Walgreens Boots Alliance shareholders |
